
SINT Stock Forecast & Price Target
SINT Analyst Ratings
Bulls say
SINTX Technologies Inc's potential for significant upside is underscored by a robust net present value (NPV) analysis, which suggests favorable conditions for the stock relative to its current valuation. The company's focus on biomedical commercialization and its recent strategic acquisition are expected to enhance its market position and drive revenue growth. Additionally, the anticipated expansion of the global antimicrobial fertilizer and crop protection market, projected to reach $10 billion by 2030, presents further opportunity for SINTX's diverse applications in antipathogenic solutions.
Bears say
SINTX Technologies Inc. reported a substantial net loss of $10.3 million for the latest period, significantly underscoring its financial challenges, particularly when compared to prior losses and expectations. The company's ongoing struggle to convert product candidates into successful market offerings is compounded by multiple risks, including liquidity issues, regulatory hurdles, competition, and changing investor sentiment towards the biotech sector. Furthermore, the repeated adjustments to price targets reflect an ongoing concern regarding the company's ability to achieve commercial viability and long-term financial stability.
This aggregate rating is based on analysts' research of SINTX Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.
SINT Analyst Forecast & Price Prediction
Start investing in SINT
Order type
Buy in
Order amount
Est. shares
0 shares